NasdaqGM:VITL
NasdaqGM:VITLFood

Viemed Healthcare And 2 Other Insider-Owned Growth Stocks To Watch

In the midst of a volatile market environment, where major stock indexes have shown resilience despite concerns about an AI bubble and ongoing government shutdown, investors are increasingly looking at companies with strong insider ownership as potential opportunities. Such stocks often signal confidence from those closest to the company's operations and can be particularly attractive in uncertain times, making Viemed Healthcare and two other insider-owned growth stocks worth watching.
NYSE:RHP
NYSE:RHPHotel and Resort REITs

Ryman Hospitality Properties (RHP) Margin Decline Challenges Bullish Narratives on Profitability Trends

Ryman Hospitality Properties (RHP) posted net profit margins of 9.6% for the latest period, a drop from last year’s 14.8% as profitability compressed. Annual earnings growth is forecast at 13.01%, with revenue expected to rise 6.8% per year, both trailing broader US market averages. Against this backdrop, investors are left weighing lower current margins and negative earnings growth over the past year in comparison to the company’s long-term trend of becoming profitable within the last five...
NYSE:SOC
NYSE:SOCOil and Gas

Sable Offshore (SOC) Is Down 54.7% After Costly Loan Amendments and Leadership Scrutiny—What's Changed

On November 3, 2025, Sable Offshore Corp. announced an amended loan agreement with Exxon Mobil, raising the interest rate to 15% and requiring Sable to secure at least US$225 million in new equity, while upholding strict cash balances. These developments coincide with a special committee investigating CEO Jim Flores over allegations of selective disclosure about funding and regulatory pressures to select investors. We'll examine how Sable Offshore's urgent equity raise and governance...
NYSE:AVA
NYSE:AVAIntegrated Utilities

How Avista's (AVA) Stronger Earnings Could Influence Its Investment Narrative and Growth Prospects

Avista Corporation reported third quarter and nine-month results, posting increases in both revenue and net income compared to the prior year, including US$403 million in quarterly sales and net income of US$29 million. This marks a period of stronger earnings performance, with basic earnings per share from continuing operations rising to US$0.36 for the quarter. We'll examine how Avista's improved quarterly profitability may shape its investment narrative and future growth outlook. We've...
NYSE:WST
NYSE:WSTLife Sciences

Is West Pharma Fairly Priced After 12.6% Drop and Biologics Packaging Buzz?

Wondering if West Pharmaceutical Services is a bargain or a bubble? You are not alone, as investors of all stripes are eager to know what the current price really means. The stock has seen mild swings recently, ticking up 1.2% over the last week and 5.3% over the past month. However, it is still down 12.6% year-to-date and 11.0% over the past year, hinting at shifting optimism and risk perceptions. Recent headlines have highlighted ongoing industry innovation and regulatory changes, putting...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Margin Miss Reinforces Concerns Over Sustained Profitability

Axcelis Technologies (ACLS) posted a net profit margin of 15.9%, down from 20.6% a year ago, as recent earnings growth turned negative. Looking ahead, analysts forecast earnings to decline by 7.3% annually over the next three years, with revenue growth expected to slow to 1.1% per year compared to a much faster 10.5% rate for the broader US market. Despite slowing fundamentals, the stock trades at a favorable 18.4x price-to-earnings ratio, which is well below its semiconductor peers, and sits...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Is There Now an Opportunity in Alliance Resource Partners After Recent Energy Sector Volatility?

If you have ever wondered whether Alliance Resource Partners shares are genuinely good value or simply riding high, you are in the right place for a clear-eyed assessment. After a strong multi-year climb of more than 1000% over five years, the stock’s momentum has slowed, with a modest 1.2% gain this week but a dip of 7.5% year-to-date. Industry headlines have centered on energy market volatility and shifting attitudes toward coal stocks. Alliance Resource Partners has appeared regularly in...
NYSE:WAT
NYSE:WATLife Sciences

Waters (WAT) Net Margin Dips, Testing Bullish Profitability Narratives

Waters (WAT) reported net profit margins of 20.9%, slightly below last year’s 21.4%. Earnings have grown by 1% annually over the past five years, with EPS up 4.3% over the past year and outpacing the longer-term trend. Revenue is projected to accelerate at 12.3% per year, while earnings are expected to climb 29.4% annually. This means both are set to outpace the broader US market. See our full analysis for Waters. Next, we will see how these fresh results line up with market narratives,...
NasdaqGS:NOVT
NasdaqGS:NOVTElectronic

Novanta (NOVT): $26 Million One-Time Loss Undermines Margin Recovery Narrative

Novanta (NOVT) posted a 7.1% annual EPS growth rate over the past five years, but in the most recent year, earnings declined and net profit margins narrowed to 5.5% from 6.5% previously. The bottom line was further impacted by a one-time, $26 million loss, resulting in another layer of pressure on last year’s results. Looking forward, consensus is calling for profits to rebound sharply at 51.5% per year over the next three years, far outpacing the broader US market's 16% annual rate. However,...
NasdaqGM:HLMN
NasdaqGM:HLMNMachinery

Hillman Solutions (HLMN): Margin Surge Reinforces Bullish Narratives Despite Valuation Concerns

Hillman Solutions (HLMN) reported net profit margins of 2.4%, up from last year’s 0.6%, reflecting a notable improvement in profitability. The company delivered a profit growth of 346.7% over the past year, significantly outpacing its five-year average of 57.2% per year. It has now maintained profitable results for several consecutive years. With forecasts pointing to annual earnings growth of 30.3%, investors are weighing the potential for continued momentum against persistent concerns about...
NYSE:MLM
NYSE:MLMBasic Materials

Profit Margin Drop at Martin Marietta (MLM) Challenges Bullish Narratives on Resilience

Martin Marietta Materials (MLM) posted a net profit margin of 17.2%, down from last year’s 30.5%, highlighting a notable decline in profitability. The results include a substantial one-off gain of $1.3 billion, impacting the latest figures. Earnings have grown at an average annual rate of 19.6% over the past five years. Looking ahead, analysts forecast earnings growth of 10.6% per year and revenue growth of 6.9% per year, both lagging the broader US market outlook. The current...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

UFP Technologies (UFPT) Margin Decline Reinforces Cautious Sentiment on Growth Outlook

UFP Technologies (UFPT) reported net profit margins of 11.2%, down from 11.7% a year ago, with recent annual earnings growth of 23.8% underperforming its five-year average of 31.6%. Looking ahead, earnings are forecast to rise at 14.33% per year and revenue growth is expected at 5.6% annually, which trails the broader US market’s 10.5% projected pace. While the company's Price-to-Earnings Ratio of 25.6x sits below the US Medical Equipment industry average but above its peer group, shares are...
NYSE:KW
NYSE:KWReal Estate

Kennedy-Wilson Stock Drops 25% in 2024 Amid Real Estate Volatility, Is Opportunity Emerging?

Wondering if Kennedy-Wilson Holdings is now a value play or if there is more trouble ahead? Let’s dive in and see whether curiosity is rewarded. The stock has tumbled in 2024, dropping 24.7% year-to-date and losing over 28% across the last twelve months as investor sentiment has shifted quickly. Recent headlines have centered on industry-wide volatility in real estate, with rising interest rates and macro uncertainty putting pressure on REITs and property holding firms like Kennedy-Wilson...
NYSE:QGEN
NYSE:QGENLife Sciences

What Do Recent Product Launches Mean for Qiagen’s Valuation in 2025?

Wondering if Qiagen is a smart buy right now? You are not alone, as there has been a lot of chatter lately about whether the current share price offers real value to investors. The stock has dipped 7.9% in the past week and 5.6% over the last month, with a somewhat muted 3.6% decline year-to-date. However, it has managed to eke out a modest 1.0% gain over the past year. Qiagen has caught attention recently with its ongoing innovations in biotech solutions and a series of new product...
NYSE:NPKI
NYSE:NPKITrade Distributors

Does NPK International’s Partnership Signal Stronger Potential After Its 81% Price Rally?

Wondering if NPK International is actually a bargain or just riding market hype? You’re not alone, and we’re about to dig into the numbers together. The stock has delivered an impressive 63.9% gain so far this year, with a substantial 80.9% return over the past 12 months. However, the last week saw a slight dip of 4.7%. Just last month, NPK International made headlines by announcing a strategic partnership aimed at expanding into new international markets. Many observers believe this move is...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

Upbound Group (UPBD): Evaluating Valuation Following Earnings Growth and CFO Appointment

Upbound Group (UPBD) just released its third-quarter results, revealing higher sales and revenue compared to last year, although profits decreased. Along with the earnings announcement, the company named Hal Khouri as its new Chief Financial Officer. See our latest analysis for Upbound Group. Despite higher sales and a new CFO appointment, Upbound Group’s recent momentum has been choppy, with a 1-year total shareholder return of -32.07% and a year-to-date share price return of -30.87%. While...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

Is Viridian Therapeutics a Bargain After Pipeline Results Spark Optimism?

Wondering if Viridian Therapeutics is truly a bargain or simply treading water? Here is a closer look at what makes this stock potentially interesting for value-minded investors. The share price climbed 8.3% in the past month but is still down 7.1% over the last year. This may suggest shifting investor sentiment and possible untapped growth. Markets have responded dynamically to the company’s recent announcement of promising results from its pipeline treatments for rare diseases. These...
NYSE:KFRC
NYSE:KFRCProfessional Services

Kforce (KFRC): Net Profit Margin Drops to 3% Reinforcing Market Caution on Growth Prospects

Kforce (KFRC) posted a net profit margin of 3%, down from 3.9% a year ago, with earnings sliding by an average of 8% per year over the past five years. Revenue is forecast to grow at just 1.5% annually, behind the broader US market’s 10.5% growth forecast, and earnings are expected to rise 10.9%, also trailing the market’s 16% target. However, the company trades at a price-to-earnings ratio of 13.7x, well below industry averages, and is noted for high quality earnings and an attractive...
NYSE:MBC
NYSE:MBCBuilding

Is MasterBrand's (MBC) Tariff Response a Test of Its Margin Resilience?

MasterBrand, Inc. recently announced third quarter 2025 earnings, reporting US$698.9 million in sales and US$18.1 million in net income, both lower than the prior year; the company also shared updated full-year guidance, anticipating flat net sales and an organic decrease by mid single-digits for 2025. In response to newly enacted tariffs, MasterBrand outlined a comprehensive plan involving pricing adjustments, supplier negotiations, and manufacturing optimization to address potential margin...
NYSE:AIN
NYSE:AINMachinery

Is Albany International’s 30% Share Price Drop in 2025 a Sign of Opportunity?

Wondering if Albany International is a hidden gem or a value trap? Let's dig into the real story behind its share price and what that could mean for you. The stock has taken a tumble recently, dropping 7.1% over the past week and down 30.5% year-to-date. This signals a shift in investor sentiment. Industry commentary has highlighted changes in market demand, company leadership, and sector headwinds as factors shaping Albany International's recent price movements. Notably, analysts and...
NYSE:DFH
NYSE:DFHConsumer Durables

Dream Finders Homes (DFH): Evaluating Valuation After Recent Share Price Decline

Dream Finders Homes (DFH) stock has been under pressure lately, giving up over 27% in the past month and about 41% over the last year. These declines raise questions regarding what is driving such persistent weakness. See our latest analysis for Dream Finders Homes. Dream Finders Homes’ rough patch has been hard to miss, with momentum clearly fading as the share price return over the past year slumped to -41.14%. Despite periods of growth in the past, this latest pullback comes as investor...